Biorithm has developed the Femom platform, a remote maternal-fetal monitoring solution that utilizes a clinical-grade fetal monitor and connected point-of-care devices to track maternal and fetal health metrics. This technology enables healthcare providers to gain real-time insights into pregnancy complications, enhancing patient engagement and continuity of care outside traditional clinical settings.
Funding
$3.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional prenatal care models often lack continuous monitoring of maternal and fetal health outside of scheduled clinic visits, potentially missing early warning signs of complications. This can lead to delayed interventions and increased risks for both mother and baby, especially for high-risk pregnancies or those with pre-existing conditions.
Solution
Biorithm offers Femom, a remote maternal-fetal monitoring platform designed to provide continuous insights into pregnancy health. The platform combines a clinical-grade fetal monitor with connected point-of-care devices and a patient-reported symptom capture to track key maternal and fetal metrics. Data is transmitted to a clinician dashboard, enabling healthcare providers to remotely monitor patients, identify potential complications early, and personalize care plans. Femom aims to improve perinatal outcomes by enhancing mother-clinician engagement and enabling data-driven clinical decision support.
Target Audience
The primary target audience includes obstetricians, maternal-fetal medicine specialists, and other healthcare providers involved in prenatal care, as well as hospitals and clinics seeking to expand their remote monitoring capabilities.
Features
- Clinical-grade fetal monitor for non-invasive recording of fetal heart rate, maternal heart rate, and uterine contractions
- Integration with connected point-of-care devices, such as blood pressure monitors and glucometers, for comprehensive maternal health tracking
- Patient mobile app for capturing patient-reported symptoms and facilitating communication with healthcare providers
- Clinician dashboard for remote monitoring of maternal and fetal health data, risk evaluation, and intervention planning
- Advanced algorithms for converting bio-metric data into CTG traces for ease of review by the care team
- Capability to support remote monitoring for both simple and complex pregnancies, including those with hypertensive disorders and gestational diabetes